Pfizer PGN 225 (Lyrica 225 mg)
Generic Name: pregabalin
Pill imprint Pfizer PGN 225 has been identified as Lyrica 225 mg.
Lyrica is used in the treatment of neuropathic pain; fibromyalgia; diabetic peripheral neuropathy; neuralgia; postherpetic neuralgia (and more), and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica 225 mg has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
See also related documents.
Images for Pfizer PGN 225 (Lyrica 225 mg)
- Generic Name:
- 225 mg
- Orange & White
- 19.00 mm
- Prescription only
- Drug Class:
- Gamma-aminobutyric acid analogs
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
sodium lauryl sulfate
ferric oxide red
|NDC Code||Manufacturer / Repackager|
|16590-0733||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about Lyrica (pregabalin)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...